Quick answer
A myocardial infarction occurs when a coronary artery blocks and heart muscle loses blood supply. The cell approach EHL Bio describes uses adult stem cells to stimulate vascular regeneration around the blockage, improving perfusion. This field began after Asahara's 1997 discovery of endothelial progenitor cells and clinical trials have expanded since, but it is not standard care in place of revascularisation.
